oncology - InSphero


November 27, 2020
Season's Greetings

2020 Year In Review: Rising to New Challenges

InSphero CEO Jan Lichtenberg extends holiday greetings from our teams in Switzerland and the United States and looks back on the highlights of 2020: a tumultuous year shaped by a […]
February 26, 2020
CAR-T Attack

Do Immuno-Oncology therapeutics make traditional in vitro assays obsolete?

InSphero Oncology Experts Francesca Chiovaro and Irina Agarkova often collaborate closely with academic and pharma partners who are developing therapeutics that target the innate immune system. In this blog, Francesca shares […]